Search Blog
March 2014
« Feb   Apr »


Newly Passed Pediatric Research Bill will Greatly Benefit Children, says Staten Island Pediatrician


By fishbat

In response to an article published by, Dr. Michael Gabriel of Gabriel Pediatrics, a Staten Island pediatric care center, says that the recently implemented bill will definitely benefit children and their parents

BROOKLYN, NY  / / ACCESSWIRE / March 28, 2014 /  Dr. Michael Gabriel of Gabriel Pediatrics, a Staten Island pediatric care center, responds to an article published on March 12 by, which reports on the newly passed pediatric research fund.

According to an article published on March 12th by Guardian liberty voice titled “Cancer Funding for Pediatrics Gets Huge Boost,” lawmakers have decided to cut the Presidential Election Campaign Fund and use the money elsewhere. Instead of funding political parties, the $126 million in savings over the next decade, will be used to advance the efforts of pediatric research on cancer, autism, and other conditions. The National Institutes of Health (NIH) will receive the funds that will be allocated to appropriate grants for research. This new bill includes a clause called the Public Health Service Act which mandates the director of the NIH to use the allotted funds specifically for pediatric research.

This bill had been created to honor the memory of a deceased young girl, Gabriella Miller, and was heavily backed by the House majority leader Eric Cantor. The Gabriella Miller Kids First Research Act successfully passed the Senate on March 12. This act will hopefully improve the survival chances of many kids who currently undergo therapy as they fight cancer to stay alive.

Dr. Michael Gabriel of Gabriel Pediatrics, a Staten Island pediatric care center, said that the passing of this bill will not only benefit pediatric patients but society as a whole as well. “Lawmakers have made a great move, this is funding for the future of America,” says Gabriel. “This is great news for America’s youth. There will be more funding for research which will yield better methods to diagnose and treat these conditions and diseases.”

Contact: Scott Darrohn,, 855-347-4228 


SOURCE: Gabriel Pediatrics

ReleaseID: 413638